FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387234006: Dexamethasone ophthalmic preparation (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1461412015 Dexamethasone ophthalmic preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481337017 Dexamethasone ophthalmic preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1461412015 Dexamethasone ophthalmic preparation (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1461412015 Dexamethasone ophthalmic preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481337017 Dexamethasone ophthalmic preparation en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1481337017 Dexamethasone ophthalmic preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Dexamethasone ophthalmic preparation Is a Dexamethasone (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing dexamethasone and tobramycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phosphate 0.1% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone+hypromellose 0.1%/0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone compound eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone 0.1% preservative-free eye drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Topical compound dexamethasone preparation (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phospha 4mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phospha 0.1% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phosphate 1.0mg/mL ophthalmic solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phospha 0.05% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phospha 1mg/cc solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone phosphate + dexamethasone sodium phospha 1mg/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phospha + lidocaine hydrochloride 0ns/10mg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phospha + neomycin sulphate 0ns/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing dexamethasone in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phosphate (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone ophthalmic preparation Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start